Jérôme Lemonnier
- Cancer Research top 10%
- Breast Cancer Treatment Studies 22
- Oncology top 5%
- Cancer Treatment and Pharmacology 12
- HER2/EGFR in Cancer Research 7
- Bone health and treatments 5
- Molecular Biology top 10%
- Bone Metabolism and Diseases 7
- Genetics top 5%
- BRCA gene mutations in cancer 7
- Connective tissue disorders research 5
- Genetics top 10%
- BRCA gene mutations in cancer 7
- Connective tissue disorders research 5
-
- Advanced Breast Cancer Therapies 25
Jérôme Lemonnier
62 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 286
- Oncology 514
- Molecular Biology 941
- Genetics 348
- Genetics 107
Countries citing papers authored by Jérôme Lemonnier
This map shows the geographic impact of Jérôme Lemonnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Lemonnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Lemonnier more than expected).
Fields of papers citing papers by Jérôme Lemonnier
This network shows the impact of papers produced by Jérôme Lemonnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Lemonnier. The network helps show where Jérôme Lemonnier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jérôme Lemonnier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 26 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 7 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 14 | |
| 9 | 2019 | 10 | |
| 10 | 2019 | 4 | |
| 11 | 2019 | 2 | |
| 12 | 2019 | 65 | |
| 13 | 2015 | 14 | |
| 14 | 2013 | 48 | |
| 15 | 2004 | 67 | |
| 16 | 2004 | 74 | |
| 17 | 2003 | 117 | |
| 18 | 2001 | 148 | |
| 19 | 2000 | 67 | |
| 20 | THYMOLIPOME M'EDIASTINAL. | 1964 | 2 |
About Jérôme Lemonnier
Jérôme Lemonnier is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 64 papers that have together received 1.6k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (25 papers), Breast Cancer Treatment Studies (22 papers), Cancer Treatment and Pharmacology (12 papers), BRCA gene mutations in cancer (7 papers), HER2/EGFR in Cancer Research (7 papers), Bone Metabolism and Diseases (7 papers), Bone health and treatments (5 papers) and Connective tissue disorders research (5 papers). The work is most often cited by research in Cancer Research (286 citations), Oncology (514 citations) and Molecular Biology (941 citations). Jérôme Lemonnier has collaborated with scholars based in France, Belgium and Switzerland. Frequent co-authors include Pierre J. Marie, Joseph Caverzasio, Eric Haÿ, Jérôme Guicheux, Chafik Ghayor, Olivia Fromigué, Abderrahim Lomri, Philippe Delannoy, Dominique Modrowski and Gaby Palmer. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.